Montanide ISA-51/peptide 946-tetanus peptide conjugate melanoma vaccine
Semantic Scholar uses AI to extract papers important to this topic.
Slow-release delivery has great potential for specifically targeting immune-modulating agents into the tumor-draining area. In… Expand A central goal in vaccinology is the induction of high and sustained Ab responses. Protein-in-adjuvant formulations are commonly… Expand BACKGROUND
A prophylactic vaccine for hepatitis C virus (HCV) requires generation of strong humoral as well as CD4(+) and CD8… Expand Previous studies in small groups of patients suggested that immunization of melanoma patients with peptide epitopes recognized by… Expand Introduction: The UBITh ® -VP1 synthetic peptide-based vaccine for FMDV O, formulated as a water-in-oil emulsion, was evaluated… Expand In a previous work we selected montanide ISA720 (M-ISA720) among different adjuvants for the vaccination with a V3 loop based… Expand